Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

788 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Ramucirumab and durvalumab for previously treated, advanced non-small-cell lung cancer, gastric/gastro-oesophageal junction adenocarcinoma, or hepatocellular carcinoma: An open-label, phase Ia/b study (JVDJ).
Bang YJ, Golan T, Dahan L, Fu S, Moreno V, Park K, Geva R, De Braud F, Wainberg ZA, Reck M, Goff L, Laing N, Mi G, Oliveira JM, Wasserstrom H, Lin CC. Bang YJ, et al. Among authors: oliveira jm. Eur J Cancer. 2020 Sep;137:272-284. doi: 10.1016/j.ejca.2020.06.007. Epub 2020 Aug 19. Eur J Cancer. 2020. PMID: 32827847 Free article. Clinical Trial.
Ramucirumab in Combination with Pembrolizumab in Treatment-Naïve Advanced Gastric or GEJ Adenocarcinoma: Safety and Antitumor Activity from the Phase 1a/b JVDF Trial.
Chau I, Penel N, Soriano AO, Arkenau HT, Cultrera J, Santana-Davila R, Calvo E, Le Tourneau C, Zender L, Bendell JC, Mi G, Gao L, McNeely SC, Oliveira JM, Ferry D, Herbst RS, Fuchs CS. Chau I, et al. Among authors: oliveira jm. Cancers (Basel). 2020 Oct 15;12(10):2985. doi: 10.3390/cancers12102985. Cancers (Basel). 2020. PMID: 33076423 Free PMC article.
Addition of ramucirumab or merestinib to standard first-line chemotherapy for locally advanced or metastatic biliary tract cancer: a randomised, double-blind, multicentre, phase 2 study.
Valle JW, Vogel A, Denlinger CS, He AR, Bai LY, Orlova R, Van Cutsem E, Adeva J, Chen LT, Obermannova R, Ettrich TJ, Chen JS, Wasan H, Girvan AC, Zhang W, Liu J, Tang C, Ebert PJ, Aggarwal A, McNeely SC, Moser BA, Oliveira JM, Carlesi R, Walgren RA, Oh DY. Valle JW, et al. Among authors: oliveira jm. Lancet Oncol. 2021 Oct;22(10):1468-1482. doi: 10.1016/S1470-2045(21)00409-5. Lancet Oncol. 2021. PMID: 34592180 Clinical Trial.
Evaluating Alternative Ramucirumab Doses as a Single Agent or with Paclitaxel in Second-Line Treatment of Locally Advanced or Metastatic Gastric/Gastroesophageal Junction Adenocarcinoma: Results from Two Randomized, Open-Label, Phase II Studies.
Shah MA, Udrea AA, Bondarenko I, Mansoor W, Sánchez RG, Sarosiek T, Bozzarelli S, Schenker M, Gomez-Martin C, Morgan C, Özgüroğlu M, Pikiel J, Kalofonos HP, Wojcik E, Buchler T, Swinson D, Cicin I, Joseph M, Vynnychenko I, Luft AV, Enzinger PC, Salek T, Papandreou C, Tournigand C, Maiello E, Wei R, Ferry D, Gao L, Oliveira JM, Ajani JA. Shah MA, et al. Among authors: oliveira jm. Cancers (Basel). 2022 Feb 24;14(5):1168. doi: 10.3390/cancers14051168. Cancers (Basel). 2022. PMID: 35267477 Free PMC article.
Control of coffee canker associated with Pseudomonas coronafaciens pv. garcae using a cocktail integrating two virulent polyvalent bacteriophages encapsulated in nanoparticles: in planta studies.
Silva EC, Rodrigues LMR, Destefano SAL, Filho OG, Braghini MT, Baldo DÂ, Oliveira JM Jr, Vila MMDC, Balcão VM. Silva EC, et al. Among authors: oliveira jm jr. J Appl Microbiol. 2024 Dec 20:lxae310. doi: 10.1093/jambio/lxae310. Online ahead of print. J Appl Microbiol. 2024. PMID: 39706671
Multiplatform Metabolomics: Enhancing the Severity Risk Prognosis of SARS-CoV-2 Infection.
Lima VS, Morais STB, Ferreira VG, Almeida MB, Silva MPB, de A Lopes T, de Oliveira JM, Raimundo JRS, Furtado DZS, Fonseca FLA, Oliveira RV, Cardoso DR, Carrilho E, Assunção NA. Lima VS, et al. Among authors: de oliveira jm. ACS Omega. 2024 Nov 6;9(46):45746-45758. doi: 10.1021/acsomega.4c02557. eCollection 2024 Nov 19. ACS Omega. 2024. PMID: 39583673 Free PMC article.
Biobased hydrogel bioinks of pectin, nanocellulose and lysozyme nanofibrils for the bioprinting of A375 melanoma cell-laden 3D in vitro platforms.
Teixeira MC, Lameirinhas NS, Carvalho JPF, Luís J, Oliveira H, Oliveira JM, Silvestre AJD, Vilela C, Freire CSR. Teixeira MC, et al. Among authors: oliveira jm. Int J Biol Macromol. 2024 Dec;282(Pt 5):136958. doi: 10.1016/j.ijbiomac.2024.136958. Epub 2024 Oct 26. Int J Biol Macromol. 2024. PMID: 39490881 Free article.
788 results